Opportunities for better medical treatment don't just happen. These opportunities are created by careful clinical research into investigational pharmaceutical therapies. At the HIV Clinical Research Unit, we create these opportunities for our patients every day. By combining our efforts with state of the art clinical facilities for HIV care at the Specialty Care Center (which includes a dental care program) our patients receive the highest quality care possible.
We offer an exceptional study and trial environment with highly qualified staff and an excellent performance record.
For both patients and physicians, this provides access to innovative experimental therapies before they are widely available. We are committed to delivering the best medical treatment: it is our mission to serve and heal.
Charurut Somboonwit MD FACP
Professor of Medicine, Division of Infectious Disease & International Medicine, University of South Florida
Director, Communicable Diseases, Florida Department of Health - Hillsborough County
|Casanas||A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus(+) Rilpivivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants with HIV-1 Who are Virologically Suppressed (SOLAR) (Protocol 213500)||Viiv Healthcare|
|Somboonwit||Health Outcomes and Cognitive Effects of Marijuana Use among Persons Living with HIV/AIDS (MAPLE)||University of Florida|
|Somboonwit||Positive Health Check (PHC)||CDC|
|Somboonwit||Randomized Trial to Prevent Vascular Events in HIV (A5332 REPRIEVE - The REPRIEVE Study)||DAIDS|
|Somboonwit||The Florida Cohort to Monitor and Improve Health Outcomes (UF Cohort)||University of Florida|
|Somboonwit||Strategic Timing of Antiretroviral Treatment (START)||University of Minnesota|
|Somboonwit||Pilot Study for Multi-site HIV/AIDS Clinical and Resource Use Database (JHU)||Johns Hopkins University|